Target intelligence / Profile preview

Pro-inflammatory cytokine production in macrophages

Molecular classification
Biological Process, Signaling Pathway, Other
01

Overview

Pro-inflammatory cytokine production in macrophages is a complex biological process where activated macrophages synthesize and secrete signaling proteins such as TNF-α, IL-1β, and IL-6 to coordinate the immune response (Source: Nature Reviews Immunology, 2017). This process is typically initiated when pattern recognition receptors, such as Toll-like receptors (TLRs), detect pathogen-associated molecular patterns (PAMPs) or endogenous danger signals (Source: NIH, StatPearls, 2023). Once activated, intracellular signaling cascades involving NF-κB and MAP kinases drive the transcription of cytokine genes (Source: Journal of Leukocyte Biology, 2020). While this response is essential for host defense and pathogen elimination, chronic or excessive cytokine production is a hallmark of various inflammatory and autoimmune disorders, including rheumatoid arthritis and sepsis (Source: Frontiers in Immunology, 2021). Therapeutic strategies often target this process by either neutralizing the secreted cytokines with monoclonal antibodies or by using small molecules to inhibit the underlying signaling pathways (Source: PubMed, 2021). Consequently, modulating macrophage cytokine output is a critical focus for treating systemic inflammatory conditions and preventing tissue damage associated with overactive immune responses.

Other names
Macrophage activationM1 macrophage polarizationPro-inflammatory cytokine releaseMacrophage-mediated inflammatory response
02

Mechanism of action

Inhibition of pro-inflammatory gene transcription via glucocorticoid receptor activation, neutralization of extracellular cytokines by monoclonal antibodies, and blockade of intracellular signaling pathways such as JAK/STAT or NF-κB.

03

Biological functions

Immune responseInflammationPathogen clearanceTissue repairCell signaling
04

Disease associations

InflammationAutoimmune diseaseSepsisRheumatoid arthritisInflammatory bowel diseaseCytokine release syndrome
05

Safety considerations

Increased risk of serious infectionsReactivation of latent tuberculosisImpaired wound healingNeutropeniaInjection site or infusion reactions
06

Interacting drugs

Dexamethasone

5 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Tumor necrosis factor-alpha (TNF-α)Interleukin-6 (IL-6)Interleukin-1 beta (IL-1β)CD80/CD86 surface expression

Beyond the preview

Go deeper on Pro-inflammatory cytokine production in macrophages.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-inflammatory cytokine production in macrophages.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call